Jeffrey Dierks, CHIEF COMMERCIAL OFFICER at Harmony Biosciences Holdings, Inc. (HRMY), sold 57,942 shares at $47.56 ($2.7M) on 2022-08-22, disclosed to the SEC on 2022-08-23.
Open-market sale of $2.7M HRMY by CHIEF COMMERCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.95 | 26,650 | $1.3M | 45.9% |
| 2 | $46.95 | 26,650 | $1.3M | 45.9% |
| 3 | $47.56 | 2,321 | $110K | 4.1% |
| 4 | $47.56 | 2,321 | $110K | 4.1% |
| Total | $47.00 avg | 57,942 | $2.7M | 100% |
| Filing → |
| HRMY | SELL | 2025-01-21 | $2.3M | — | Filing → |
| HRMY | SELL | 2025-01-16 | $778K | — | Filing → |
| HRMY | SELL | 2025-01-15 | $532K | — | Filing → |